TCF4 and melanoma: Pozniak et al. integrated single-cell transcriptomics with spatial transcriptomics and proteomics to investigate melanoma, revealing a TCF4-dependent regulatory network, which orchestrated multiple transcriptional programs leading to immunotherapy resistance [202].